Bactroban

Bactroban is a brand name of mupirocin topical, approved by the FDA in the following formulation(s):

BACTROBAN (mupirocin - ointment; topical)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: December 31, 1987
  
  Strength(s): 2% ^[RLD][AB]

BACTROBAN (mupirocin calcium - cream; topical)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: December 11, 1997
  
  Strength(s): EQ 2% BASE ^[RLD]

BACTROBAN (mupirocin calcium - ointment; nasal)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: September 18, 1995
  
  Strength(s): EQ 2% BASE ^[RLD]

Has a generic version of Bactroban been approved?

A generic version of Bactroban has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Bactroban and have been approved by the FDA:

mupirocin ointment; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: November 30, 2005
  
  Strength(s): 2% ^[AB]


• 
  Manufacturer: GLENMARK PHARMS
  
  Approval date: June 8, 2011
  
  Strength(s): 2% ^[AB]


• 
  Manufacturer: PERRIGO NEW YORK
  
  Approval date: November 7, 2003
  
  Strength(s): 2% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: September 23, 2005
  
  Strength(s): 2% ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: November 7, 2003
  
  Strength(s): 2% ^[AB]

Note: No generic formulation of the following products are available.

• mupirocin calcium - cream; topical


• mupirocin calcium - ointment; nasal

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Bactroban. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical and veterinary compositions of mupirocin and methods for their preparation
  Patent 6,025,389
  Issued: February 15, 2000
  Inventor(s): Zimmerman; Harvey Lee
  Assignee(s): SmithKline Beecham Corporation
  The invention is directed to a pharmaceutical composition comprising a cream base which comprises mupiricin dihydrate, a mineral oil, one or more fatty alcohols or fatty esters, a polyoxyethylene ether or ester surfactant, xanthan gum, water and a method for treating a bacterial infection using said composition.
  
  Patent expiration dates:
  
  
  • October 20, 2014
    
    ✓ 
    Patent use: TREATMENT OF SECONDARILY INFECTED TRAUMATIC SKIN LESIONS DUE TO S. AUREUS AND S. PYOGENES
    ✓ 
    Drug product
  
  

See also...

• Bactroban Consumer Information (Drugs.com)
• Bactroban Cream Consumer Information (Wolters Kluwer)
• Bactroban Ointment Consumer Information (Wolters Kluwer)
• Bactroban Consumer Information (Cerner Multum)
• Bactroban Nasal Advanced Consumer Information (Micromedex)
• Bactroban Topical Advanced Consumer Information (Micromedex)
• Mupirocin Cream Consumer Information (Wolters Kluwer)
• Mupirocin Ointment Consumer Information (Wolters Kluwer)
• Mupirocin nasal Consumer Information (Cerner Multum)
• Mupirocin topical Consumer Information (Cerner Multum)
• Mupirocin Nasal Advanced Consumer Information (Micromedex)
• Mupirocin Topical Advanced Consumer Information (Micromedex)
• Mupirocin AHFS DI Monographs (ASHP)